Zolpidem and risk of falls; AVR and anticoagulation; statins in cancer patients; and FDA actions.
This study, the Multicenter Automatic Defibrillator Implantation Trial Reduce Inappropriate Therapy (MADIT-RIT), was designed to test the hypothesis that programming implantable cardioverter-defibrillator (ICD) therapies with higher detection rates or delayed detection before initiation of therapy would decrease inappropriate shocks in ICD patients.
30-day all-cause hospital admission rates lowered in older patients with chronic systolic heart failure who were started on digoxin when compared to placebo.
This article originally appeared in the August 29, 2013, issue of Internal Medicine Alert
Evidence-based updates in primary care medicine By Louis Kuritzky, MD
Supplement to Clinical Cardiology Alert, Clinical Oncology Alert, Critical Care Alert, Hospital Medicine Alert, Infectious Disease Alert, Neurology Alert, OB/GYN Clinical Alert, Primary Care Reports.
Supplements and herbal medications have extensive worldwide use; in the United States alone, more than $5 billion was spent on herbal supplements in 2012.